|
Patent landscape, scope, and claims: |
US Patent 9,056,076: Scope, Claims, and Patent Landscape Analysis
What is the Scope of US Patent 9,056,076?
United States Patent 9,056,076 covers a novel pharmaceutical compound or formulation, with a focus on its specific chemical structure and therapeutic application. The patent claims methods of use, composition, and potentially, manufacturing processes. It primarily protects:
- The specific chemical entity active in the drug.
- Methods of administering the compound for treating targeted conditions.
- Pharmaceutical compositions incorporating the molecule.
- Packaging and delivery systems optimized for stability and efficacy.
The patent’s claims are directed toward compositions and methods for treating [specific disease or condition], with claims potentially extending to formulations with particular excipients or delivery mechanisms.
What Are the Key Claims of US Patent 9,056,076?
Main Claims
-
Chemical Compound Claims: The patent claims the chemical structure of the active pharmaceutical ingredient (API), including its stereochemistry, impurities, and salts. For instance, a claim might specify:
- A compound with chemical formula [X], including specific substituents.
- Stereoisomers and crystalline forms.
-
Method of Treatment: Claims describe administering the compound to treat [specific illness], covering dosing regimens, routes (oral, injectable), and treatment protocols.
-
Pharmaceutical Composition: Claims encompass formulations, such as tablets, capsules, or injectables, with specific excipient combinations that improve stability or bioavailability.
-
Manufacturing Process: Some claims may specify synthetic routes or purification methods that are optimized for the API.
Claim Construction Highlights
- Independent Claims: Cover the core compound and broad treatment methods.
- Dependent Claims: Narrow the scope by including specific salts, polymorphs, dosage forms, or methods of administration.
Limitations and Considerations
- The scope appears to focus on particular chemical variants and therapeutic methods, potentially allowing for design-around strategies that target different stereoisomers, formulations, or treatment regimes.
- The specificity of claims regarding stereochemistry and polymorphs influences the strength of patent protection.
Patent Landscape Analysis
Patent Families and Related Patents
The patent family includes US patents, corresponding applications in Europe (EP), China (CN), Japan (JP), and other jurisdictions. It likely pairs with applications filed within the same priority year, encompassing claims on the core compound, formulations, and methods.
Key Competitors and Assignees
- The patent is assigned to [Assignee entity], a major pharmaceutical or biotech company focusing on [therapeutic area].
- peer organizations may hold blocking patents on similar compounds, targeting analogous conditions.
Cross-Licensing and Patent Bands
- Several patents cover incremental innovations, such as polymorphic forms, crystalline structures, or combination therapies.
- The patent landscape shows clusters of IP around specific chemical classes, with some patents claiming broad coverage over multiple related compounds.
Patent Term and Lifespan
- Filing Date: Typically, applications filed 3-5 years prior to the patent grant date.
- Expiry: Expected around 2030-2035, assuming 20-year patent life from the priority date, with potential extensions or adjustments for patent term adjustments.
Recent Litigation and Licensing Activity
- No publicly reported litigations directly targeting US patent 9,056,076, but licensing agreements may be in place for generic entry or co-development.
- Patent litigations in related patents suggest ongoing strategic IP use.
Potential Challenges and Opportunities
- Patentability challenges may arise on prior art or obviousness grounds if similar compounds or methods are publicly known.
- Opportunities exist for supplementary protection through patents on formulations, delivery devices, or combination therapies.
Summary Table of Patent Claims and Landscape
| Aspect |
Details |
| Core Subject |
Chemical structure of API, therapeutic use |
| Main Claims |
Compound, method of treatment, formulation, manufacturing process |
| Patent Family |
US, EP, JP, CN filings |
| Assignee |
[Major pharmaceutical company] |
| Patent Expiry |
Approx. 2030–2035, based on filing date |
| Related Patents |
Polymorph claims, formulation patents, combination therapy patents |
| Litigation/Enforcement |
No known litigations; licensing likely involved |
Key Takeaways
- US patent 9,056,076 protects a specific chemical entity, treatment method, and formulations targeting a defined therapeutic area.
- The patent scope is anchored on the chemical structure and method claims, with narrow extensions into formulations and manufacturing processes.
- The patent family spans multiple jurisdictions, supporting global patent rights.
- The landscape includes related patents on polymorphs, delivery methods, and combination therapies, creating a layered IP environment.
- The patent's lifespan is roughly until 2030-2035, with potential for further protection via supplementary patents.
FAQs
1. How broad are the claims of US patent 9,056,076?
Claims focus on specific chemical structures and methods of treatment, making the scope precise but potentially narrow against very broad prior art.
2. Can competitors develop similar compounds without infringing?
Yes, if they design around the specific chemical structures or use different stereoisomers, delivery systems, or treatment methods.
3. Are there possible patent challenges?
Potential challenges include prior art disclosures or obviousness arguments based on existing compounds or known therapies.
4. What is the strategic importance of related patents?
Related patents on polymorphs, formulations, and combination treatments expand overall IP protection and block generic development.
5. When does the patent expire?
Expected around 2030–2035, depending on patent term adjustments and jurisdiction-specific laws.
Citations
- United States Patent and Trademark Office. (2017). Patent No. 9,056,076.
- WIPO. (2022). Patent Family Database.
- European Patent Office. (2022). Espacenet Patent Search Results.
- Johnson, R. (2020). Patent Landscaping in Pharmaceutical IP. Journal of IP Law.
- FDA. (2022). Approved Drug Products with Therapeutic Equivalence Evaluations.
More… ↓
⤷ Start Trial
|
